Among Hsa-miR-139-5p possible targets we found H2AFV, an histone family member, and Lysosome Transmembrane Protein 4-Beta (LAPTM4B), an oncoprotein originally identified in hepatocellular carcinomas [160]–[161], whose over-expression has been already associated with BC susceptibility and prognosis [162]–[163]. The gene discussed is LAPTM4B; the disease is hepatocellular carcinoma.